Health Condition 1: - Health Condition 2: D059- Unspecified type of carcinoma in situ of breast
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients giving consent 2. Females ages 30-65 undergoing breast surgery 3. ASA physical status I and II
Exclusion criteria
Exclusion criteria: 1. patients who do not give consent 2. patients on anticoagulant therapy 3. ASA status > II 4. patients having chest wall deformity or local site infection 5. allergic to local anaesthetics 6. serious neurological amd psychaitric disorders 7. patients already on gabapentin or other anticonvulsant 8. hepatic or renal dysfunction
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. intensity of pain at 2 hourly intervals for first 24 hours post operatively using VAS score 2. time of rescue analgesiaTimepoint: 2 hourly interval for first 24 hours in post operative period | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Intraoperative and postoperative hemodynamic changes 2. Evaluating adverse effects of Gabapentin like nausea, vomiting, sedation 3. Total analgesic consumption upto 24 hours after surgeryTimepoint: intraoperative and postoperatively for 24 hours | — |
Countries
India
Contacts
DR. RAM MANOHAR LOHIA INSTITUTE OF MEDICAL SCIENCES